Uçucular (Tiner, Benzin, Gazolin, Bali vb.) Kullanım Bozukluğu ve Ebelik Yaklaşımı
References
Earnshaw VA. Stigma and substance use disorders: A clinical, research, and advocacy agenda. American Psychologist. 2020; 75(9): 1300–1311.
Volkow ND, Blanco C. Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention. World Psychiatry. 2023; 22(2): 203–229.
Öz HS. Bütan-Propan gaz bağımlılığı ile geçen 19 yıl: bir olgu sunumu. Hacettepe Üniversitesi Hemşirelik Fakültesi Dergisi. 2021; 8(3): 346–352.
Alonso-Matías L, Reyes-Zamorano E, González-Olvera JJ, Alonso-Matías L, Reyes-Zamorano E, González-Olvera JJ. Cognitive and clinic profile of volatile substance users. Salud Mental. 2020; 43(4): 167–174.
Hamid Boztaş M, Arısoy Ö. Uçucu madde bağımlılığı ve tıbbi sonuçları. Psikiyatride Güncel Yaklaşımlar. 2010; 2(4): 516–531.
Bozabalı S, Ülger Z, Levent E, Özyürek AR. Uçucu madde bağımlısı bir gençte görülen atrial flutter. Ege Tıp Dergisi, 2017;56(3):145-7.
Hong IZ, Ponampalam R. Death related to ethyl chloride inhalation abuse: a case report. World J Emerg Med. 2022 13(5): 422.
Vahabzadeh M, Mégarbane B. A two-decade review of butane toxicity as a substance of abuse. Basic Clin Pharmacol Toxicol. 2022; 131(3): 155–164.
Romanelli F, Smith KM, Thornton AC, Pomeroy C. Poppers: Epidemiology and clinical management of inhaled nitrite abuse. Pharmacotherapy. 2004; 24(1): 69–78.
Pepper N, Zúñiga ML, Corliss HL. Use of poppers (nitrite inhalants) among young men who have sex with men with HIV: A clinic-based qualitative study. BMC Public Health. 2024; 24(1): 1–15.
El-Sikaily A, Helal M, Nsonwu-Anyanwu AC, Azab H, Abd ElMoneim N, Farahat EOS, et al. Impacts of PAH accumulation on reproductive hormones, indices of oxidative stress and BPDE-albumin adduct in women with recurrent pregnancy loss. Toxicol Res. 2023; 39(3): 517–531.
Radparvar S. The clinical assessment and treatment of inhalant abuse. Perm J. 2023; 27(2): 99.
Romolo FS, di Luca NM, Ciallella C, Bottoni E, Fiore PA, Cappelletti S, et al. Volatile lipophilic substances management in case of fatal sniffing. J Forensic Leg Med. 2017; 52: 35–39.
Adenugba AA, Okeshola FB. Substance Abuse among Females in Nigeria. International Journal of Business and Social Science. 2018; 9(5): 99-105.
De Boer T, Distasio J, Isaak CA, Roos LE, Bolton SL, Medved M, et al. What are the predictors of volatile substance use in an urban community of adults who are homeless? Canadian Journal of Community Mental Health. 2015; 34(2):1–15.
Kott P, Hedden S, Aldworth J, Bose J, Chromy J, Gfroerer J, et al. 2012 National Survey on Drug Use and Health: A Revised Strategy for Estimating the Prevalence of Mental Illness. Rockville (MD): Substance Abuse and Mental Health Services Administration (US). CBHSQ Methodology Report. 2013; Erişim adresi: https://www.ncbi.nlm.nih.gov/books/NBK531551/ Erişim tarihi: 31.10.24.
Forray A. Substance use during pregnancy. F1000Research. 2016; 5(May): 1–9.
Harrison P, Cowen P, Burns T, Fazel M. Shorter Oxford Textbook of Psychiatry. Shorter Oxford Textbook of Psychiatry. 2017 Oct; Erişim adresi: https://doi.org/10.1093/med/9780198747437.001.0001 Erişim tarihi: 31.10.24.
Jones HE, Balster RL. Inhalant abuse in pregnancy. Obstet Gynecol Clin North Am. 1998; 25(1): 153–167.
Volkow ND, Morales M. The Brain on Drugs: From Reward to Addiction. Cell. 2015; 162(4): 712–725.
Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016; 3(8): 760.
Wise RA, Koob GF. The Development and Maintenance of Drug Addiction. Neuropsychopharmacology. 2014; 39(2): 254.
Everitt BJ, Robbins TW. Drug Addiction: Updating Actions to Habits to Compulsions Ten Years On. Annu Rev Psychol. 2016; 67: 23–50.
Storck M, Black L, Liddell M. Inhalant abuse and dextromethorphan. Child Adolesc Psychiatr Clin N Am. 2016; 25(3): 497–508.
Williams JF, Storck M, Joffe A, Behnke M, Knight JR, Kokotailo PK, et al. Inhalant abuse. Pediatrics. 2007; 119(5): 1009–117.
Ertuğrul Köroğlu. DSM-5 Tanı Ölçütleri Başvuru El Kitabı. Universitas Nusantara PGRI Kediri. 2013; pp.231–291. ISBN: 9789753001984.
Dilbaz N. Madde bağımlılığında korunma ve tedavi ı̇lkeleri̇. T. C. Sağlık Bakanlığı Sağlık Hizmetleri Genel Müdürlüğü, Madde Bağımlılığı Tanı ve Tedavi Kılavuzu El Kitabı. 2012; pp. 105–124. ISBN: 978-975-590-431-3.
Casley M, Harris P, Tilbury C, Gallagher N. Community responses to volatile substance misuse by children: A scoping review. Child Youth Serv Rev. 2022; 139: 106567.
Alonso-Matías, Lizeth, Ernesto Reyes-Zamorano, and Jorge J. González-Olvera. "Clinical and behavioral profile of young inhalant users." Actas Españolas de Psiquiatría 47.5 (2019): 171-178.
Rosenberg NL, Grigsby J, Dreisbach J, Busenbark D, Grigsby P. Neuropsychologic impairment and MRI abnormalities associated with chronic solvent abuse. J Toxicol Clin Toxicol. 2002; 40(1): 21–34.
Duret E, Blanchot A, Ameline A, Kintz P. Quand l’activité sexuelle solitaire tourne au drame. Comment objectiver une prise de «poppers» en post-mortem? Toxicologie Analytique et Clinique. 2024. Erişim adresi: https://doi.org/10.1016/j.toxac.2024.02.003 Erişim tarihi: 31.10.24.
Howard MO, Bowen SE, Garland EL, Perron BE, Vaughn MG. Inhalant use and inhalant use disorders in the United States. Addiction Science & Clinical Practice. 2011; 6(1): 18.
Narkotik Suçlarla Mücadele Başkanlığı. 2023 Türkiye Uyuşturucu Raporu. 2023. Erişim adresi: https://www.narkotik.pol.tr/2023-turkiye-uyusturucu-raporu-yayinlanmistir Erişim tarihi: 31.10.24.
Nath P, Kilam S, Swetapadma A. A machine learning approach to predict volatile substance abuse for drug risk analysis. Proceedings - 2017 3rd IEEE International Conference on Research in Computational Intelligence and Communication Networks, ICRCICN 2017. 2017;255–258. Erişim adresi: https://ieeexplore.ieee.org/document/8234516; Erişim tarihi:31.10.24.
Radparvar S. The clinical assessment and treatment of inhalant abuse. Perm J. 2023; 27(2): 99.
Şirin H, Uzun ME. Sociodemographic and clinical characteristics of adolescent patients treated in ÇEMATEM with the diagnosis of substance use disorders: Bursa sample. Turkish Journal of Child and Adolescent Mental Health. 2021; 28(2): 151–158.
Shafer G, Arunachalam A, Lohmann P. Newborn with perinatal naphthalene toxicity after maternal ıngestion of mothballs during. Pregnancy. Neonatology. 2020; 117(1): 127–130.
Crocetti M, Serwint JR. Inhalants. Pediatr Rev. 2008; 29(1): 33–4.
Baydala L. Inhalant abuse. Paediatrics & child health. 2010; 15(7): 443–448.
Vural M, Ogel K. Dilated cardiomyopathy associated with toluene abuse. Cardiology. 2006; 105(3): 158–161.
Lin HM, Liu CY, Jow GM, Tang CY. Toluene disrupts synaptogenesis in cultured hippocampal neurons. Toxicol Lett. 2009; 184(2): 90–96.
Dias PJ. Adolescent substance abuse. Assessment in the office. Pediatr Clin North Am. 2002; 49(2): 269–300.
Kulig JW. Tobacco, alcohol, and other drugs: the role of the pediatrician in prevention, identification, and management of substance abuse. Pediatrics. 2005; 115(3): 816–821.
Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007; 64(5): 566–576.
Stinson FS, Grant BF, Dawson DA, Ruan WJ, Huang B, Saha T. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2005; 80(1): 105–16.
Forray A. Substance use during pregnancy [ version 1 ; peer review : 2 approved ]. F1000Research. 2019; 5(May 2016): 1–8.
Lundsberg LS, Illuzzi JL, Belanger K, Triche EW, Bracken MB. Low-to-moderate prenatal alcohol consumption and the risk of selected birth outcomes: a prospective cohort study. Ann Epidemiol. 2015; 25(1): 46-54.
National Survey on Drug Use and Health, 2012. Erişim adresi: https://www.icpsr.umich.edu/web/NAHDAP/studies/34933 Erişim tarihi: 31.10.24.
Wright TE, Schuetter R, Tellei J, Sauvage L. Methamphetamines and pregnancy outcomes. J Addict Med. 2015; 9(2): 111–117.
Minozzi S, Amato L, Jahanfar S, Bellisario C, Ferri M, Davoli M. Maintenance agonist treatments for opiate-dependent pregnant women. Cochrane Database of Systematic Reviews. 2020; 2020(11).
Lee MR, Glassman M, King-Casas B, Kelly DL, Stein EA, Schroeder J, et al. Complexity of oxytocin’s effects in a chronic cocaine dependent population. European Neuropsychopharmacology. 2014; 24(9): 1483–1491.
Love TM. Oxytocin, motivation and the role of dopamine. Pharmacol Biochem Behav. 2014; 119: 49–60.
Muller AA, Muller GF. Inhalant abuse. J Emerg Nurs. 2006; 32(5): 447–8.
Anderson CE, Loomis GA. Recognition and prevention of inhalant abuse. Am Fam Physician. 2003; 68(5): 869–874.
Jaffe SL. Treatment and relapse prevention for adolescent substance abuse. Pediatr Clin North Am. 2002; 49(2): 345–352.
Toumbourou J, Stockwell T, Neighbors C, Marlatt G, Sturge J, Rehm J. Interventions to reduce harm associated with adolescent substance use. Lancet. 2007; 369(9570): 1391–401.
Wimalasiri I, Suraweera C. All in a scent - naphthalene dependence confined to pregnancy: a case report. BMC Psychiatry. 2022; 22(1): 1–4.
Wilton G, Moberg DP, Van Stelle KR, Dold LL, Obmascher K, Goodrich J. A randomized trial comparing telephone versus in-person brief intervention to reduce the risk of an alcohol-exposed pregnancy. J Subst Abuse Treat. 2013; 45(5): 389–394.
Volkow ND, Blanco C. Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention. World Psychiatry. 2023; 22(2): 203–229.
Öz HS. Bütan-Propan gaz bağımlılığı ile geçen 19 yıl: bir olgu sunumu. Hacettepe Üniversitesi Hemşirelik Fakültesi Dergisi. 2021; 8(3): 346–352.
Alonso-Matías L, Reyes-Zamorano E, González-Olvera JJ, Alonso-Matías L, Reyes-Zamorano E, González-Olvera JJ. Cognitive and clinic profile of volatile substance users. Salud Mental. 2020; 43(4): 167–174.
Hamid Boztaş M, Arısoy Ö. Uçucu madde bağımlılığı ve tıbbi sonuçları. Psikiyatride Güncel Yaklaşımlar. 2010; 2(4): 516–531.
Bozabalı S, Ülger Z, Levent E, Özyürek AR. Uçucu madde bağımlısı bir gençte görülen atrial flutter. Ege Tıp Dergisi, 2017;56(3):145-7.
Hong IZ, Ponampalam R. Death related to ethyl chloride inhalation abuse: a case report. World J Emerg Med. 2022 13(5): 422.
Vahabzadeh M, Mégarbane B. A two-decade review of butane toxicity as a substance of abuse. Basic Clin Pharmacol Toxicol. 2022; 131(3): 155–164.
Romanelli F, Smith KM, Thornton AC, Pomeroy C. Poppers: Epidemiology and clinical management of inhaled nitrite abuse. Pharmacotherapy. 2004; 24(1): 69–78.
Pepper N, Zúñiga ML, Corliss HL. Use of poppers (nitrite inhalants) among young men who have sex with men with HIV: A clinic-based qualitative study. BMC Public Health. 2024; 24(1): 1–15.
El-Sikaily A, Helal M, Nsonwu-Anyanwu AC, Azab H, Abd ElMoneim N, Farahat EOS, et al. Impacts of PAH accumulation on reproductive hormones, indices of oxidative stress and BPDE-albumin adduct in women with recurrent pregnancy loss. Toxicol Res. 2023; 39(3): 517–531.
Radparvar S. The clinical assessment and treatment of inhalant abuse. Perm J. 2023; 27(2): 99.
Romolo FS, di Luca NM, Ciallella C, Bottoni E, Fiore PA, Cappelletti S, et al. Volatile lipophilic substances management in case of fatal sniffing. J Forensic Leg Med. 2017; 52: 35–39.
Adenugba AA, Okeshola FB. Substance Abuse among Females in Nigeria. International Journal of Business and Social Science. 2018; 9(5): 99-105.
De Boer T, Distasio J, Isaak CA, Roos LE, Bolton SL, Medved M, et al. What are the predictors of volatile substance use in an urban community of adults who are homeless? Canadian Journal of Community Mental Health. 2015; 34(2):1–15.
Kott P, Hedden S, Aldworth J, Bose J, Chromy J, Gfroerer J, et al. 2012 National Survey on Drug Use and Health: A Revised Strategy for Estimating the Prevalence of Mental Illness. Rockville (MD): Substance Abuse and Mental Health Services Administration (US). CBHSQ Methodology Report. 2013; Erişim adresi: https://www.ncbi.nlm.nih.gov/books/NBK531551/ Erişim tarihi: 31.10.24.
Forray A. Substance use during pregnancy. F1000Research. 2016; 5(May): 1–9.
Harrison P, Cowen P, Burns T, Fazel M. Shorter Oxford Textbook of Psychiatry. Shorter Oxford Textbook of Psychiatry. 2017 Oct; Erişim adresi: https://doi.org/10.1093/med/9780198747437.001.0001 Erişim tarihi: 31.10.24.
Jones HE, Balster RL. Inhalant abuse in pregnancy. Obstet Gynecol Clin North Am. 1998; 25(1): 153–167.
Volkow ND, Morales M. The Brain on Drugs: From Reward to Addiction. Cell. 2015; 162(4): 712–725.
Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016; 3(8): 760.
Wise RA, Koob GF. The Development and Maintenance of Drug Addiction. Neuropsychopharmacology. 2014; 39(2): 254.
Everitt BJ, Robbins TW. Drug Addiction: Updating Actions to Habits to Compulsions Ten Years On. Annu Rev Psychol. 2016; 67: 23–50.
Storck M, Black L, Liddell M. Inhalant abuse and dextromethorphan. Child Adolesc Psychiatr Clin N Am. 2016; 25(3): 497–508.
Williams JF, Storck M, Joffe A, Behnke M, Knight JR, Kokotailo PK, et al. Inhalant abuse. Pediatrics. 2007; 119(5): 1009–117.
Ertuğrul Köroğlu. DSM-5 Tanı Ölçütleri Başvuru El Kitabı. Universitas Nusantara PGRI Kediri. 2013; pp.231–291. ISBN: 9789753001984.
Dilbaz N. Madde bağımlılığında korunma ve tedavi ı̇lkeleri̇. T. C. Sağlık Bakanlığı Sağlık Hizmetleri Genel Müdürlüğü, Madde Bağımlılığı Tanı ve Tedavi Kılavuzu El Kitabı. 2012; pp. 105–124. ISBN: 978-975-590-431-3.
Casley M, Harris P, Tilbury C, Gallagher N. Community responses to volatile substance misuse by children: A scoping review. Child Youth Serv Rev. 2022; 139: 106567.
Alonso-Matías, Lizeth, Ernesto Reyes-Zamorano, and Jorge J. González-Olvera. "Clinical and behavioral profile of young inhalant users." Actas Españolas de Psiquiatría 47.5 (2019): 171-178.
Rosenberg NL, Grigsby J, Dreisbach J, Busenbark D, Grigsby P. Neuropsychologic impairment and MRI abnormalities associated with chronic solvent abuse. J Toxicol Clin Toxicol. 2002; 40(1): 21–34.
Duret E, Blanchot A, Ameline A, Kintz P. Quand l’activité sexuelle solitaire tourne au drame. Comment objectiver une prise de «poppers» en post-mortem? Toxicologie Analytique et Clinique. 2024. Erişim adresi: https://doi.org/10.1016/j.toxac.2024.02.003 Erişim tarihi: 31.10.24.
Howard MO, Bowen SE, Garland EL, Perron BE, Vaughn MG. Inhalant use and inhalant use disorders in the United States. Addiction Science & Clinical Practice. 2011; 6(1): 18.
Narkotik Suçlarla Mücadele Başkanlığı. 2023 Türkiye Uyuşturucu Raporu. 2023. Erişim adresi: https://www.narkotik.pol.tr/2023-turkiye-uyusturucu-raporu-yayinlanmistir Erişim tarihi: 31.10.24.
Nath P, Kilam S, Swetapadma A. A machine learning approach to predict volatile substance abuse for drug risk analysis. Proceedings - 2017 3rd IEEE International Conference on Research in Computational Intelligence and Communication Networks, ICRCICN 2017. 2017;255–258. Erişim adresi: https://ieeexplore.ieee.org/document/8234516; Erişim tarihi:31.10.24.
Radparvar S. The clinical assessment and treatment of inhalant abuse. Perm J. 2023; 27(2): 99.
Şirin H, Uzun ME. Sociodemographic and clinical characteristics of adolescent patients treated in ÇEMATEM with the diagnosis of substance use disorders: Bursa sample. Turkish Journal of Child and Adolescent Mental Health. 2021; 28(2): 151–158.
Shafer G, Arunachalam A, Lohmann P. Newborn with perinatal naphthalene toxicity after maternal ıngestion of mothballs during. Pregnancy. Neonatology. 2020; 117(1): 127–130.
Crocetti M, Serwint JR. Inhalants. Pediatr Rev. 2008; 29(1): 33–4.
Baydala L. Inhalant abuse. Paediatrics & child health. 2010; 15(7): 443–448.
Vural M, Ogel K. Dilated cardiomyopathy associated with toluene abuse. Cardiology. 2006; 105(3): 158–161.
Lin HM, Liu CY, Jow GM, Tang CY. Toluene disrupts synaptogenesis in cultured hippocampal neurons. Toxicol Lett. 2009; 184(2): 90–96.
Dias PJ. Adolescent substance abuse. Assessment in the office. Pediatr Clin North Am. 2002; 49(2): 269–300.
Kulig JW. Tobacco, alcohol, and other drugs: the role of the pediatrician in prevention, identification, and management of substance abuse. Pediatrics. 2005; 115(3): 816–821.
Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007; 64(5): 566–576.
Stinson FS, Grant BF, Dawson DA, Ruan WJ, Huang B, Saha T. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2005; 80(1): 105–16.
Forray A. Substance use during pregnancy [ version 1 ; peer review : 2 approved ]. F1000Research. 2019; 5(May 2016): 1–8.
Lundsberg LS, Illuzzi JL, Belanger K, Triche EW, Bracken MB. Low-to-moderate prenatal alcohol consumption and the risk of selected birth outcomes: a prospective cohort study. Ann Epidemiol. 2015; 25(1): 46-54.
National Survey on Drug Use and Health, 2012. Erişim adresi: https://www.icpsr.umich.edu/web/NAHDAP/studies/34933 Erişim tarihi: 31.10.24.
Wright TE, Schuetter R, Tellei J, Sauvage L. Methamphetamines and pregnancy outcomes. J Addict Med. 2015; 9(2): 111–117.
Minozzi S, Amato L, Jahanfar S, Bellisario C, Ferri M, Davoli M. Maintenance agonist treatments for opiate-dependent pregnant women. Cochrane Database of Systematic Reviews. 2020; 2020(11).
Lee MR, Glassman M, King-Casas B, Kelly DL, Stein EA, Schroeder J, et al. Complexity of oxytocin’s effects in a chronic cocaine dependent population. European Neuropsychopharmacology. 2014; 24(9): 1483–1491.
Love TM. Oxytocin, motivation and the role of dopamine. Pharmacol Biochem Behav. 2014; 119: 49–60.
Muller AA, Muller GF. Inhalant abuse. J Emerg Nurs. 2006; 32(5): 447–8.
Anderson CE, Loomis GA. Recognition and prevention of inhalant abuse. Am Fam Physician. 2003; 68(5): 869–874.
Jaffe SL. Treatment and relapse prevention for adolescent substance abuse. Pediatr Clin North Am. 2002; 49(2): 345–352.
Toumbourou J, Stockwell T, Neighbors C, Marlatt G, Sturge J, Rehm J. Interventions to reduce harm associated with adolescent substance use. Lancet. 2007; 369(9570): 1391–401.
Wimalasiri I, Suraweera C. All in a scent - naphthalene dependence confined to pregnancy: a case report. BMC Psychiatry. 2022; 22(1): 1–4.
Wilton G, Moberg DP, Van Stelle KR, Dold LL, Obmascher K, Goodrich J. A randomized trial comparing telephone versus in-person brief intervention to reduce the risk of an alcohol-exposed pregnancy. J Subst Abuse Treat. 2013; 45(5): 389–394.
Pages
103-124
Published
January 22, 2025
Copyright (c) 2025 Academician Publishing Book Portal
